Smartphones and Apps to Control Glycosylated Hemoglobin (HbA1c) Level in Diabetes: A Systematic Review and Meta-Analysis
Metadatos
Afficher la notice complèteAuteur
Martos Cabrera, Maria; Velando Soriano, Almudena; Pradas-Hernández, Laura; Suleiman Martos, Nora; Cañadas De La Fuente, Guillermo Arturo; Albendín García, Luis; Gómez Urquiza, Jose LuisEditorial
MDPI
Materia
Glycosylated hemoglobin Health education Prevention and control Diabetes mellitus Smartphone application
Date
2020-03-04Referencia bibliográfica
Martos-Cabrera, M. B., Velando-Soriano, A., Pradas-Hernández, L., Suleiman-Martos, N., Albendín-García, L., & Gómez-Urquiza, J. L. (2020). Smartphones and Apps to Control Glycosylated Hemoglobin (HbA1c) Level in Diabetes: A Systematic Review and Meta-Analysis. Journal of clinical medicine, 9(3), 693.
Résumé
Introduction: Diabetes mellitus is a chronic endocrine-metabolic disease, the evolution of
which is closely related to people’s self-control of glycemic levels through nutrition, exercise, and
medicines. Aim: To determine whether smartphone apps can help persons with diabetes to improve
their % levels of glycosylated hemoglobin. Method: A systematic review and meta-analysis were
done. ProQuest, Pubmed/Medline, and Scopus databases were used. The search equation used
was “(Prevention and Control) AND Diabetes Mellitus AND Smartphones”. The inclusion criteria
applied were clinical trials, conducted in 2014–2019. Results: n = 18 studies were included in the
review. The studies tried different applications to monitor glycemia and support patients to improve
glycosylated hemoglobin (HbA1c) levels. More than half of the studies found statistically significant
differences in HbA1c in the intervention group compared with the control group. Eleven studies
were included in the meta-analysis and the study sample was n = 545 for the experimental group and
n = 454 for the control group. The meta-analytic estimation of the HbA1c % level means differences
between intervention and control group was statistically significant in favour of the intervention
group with a mean difference of –0.37 (–0.58, –0.15. 95% confidence interval). Conclusion: Smartphone
apps can help people with diabetes to improve their level of HbA1c, but the clinical impact is low.